Synvista Therapeutics, Inc. (SYNI)
OTCMKTS
· Delayed Price · Currency is USD
0.0000
0.00 (0.00%)
At close: Aug 14, 2025
Synvista Therapeutics Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2007 | FY 2006 | FY 2005 | FY 2004 | FY 2003 | 1998 - 2002 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '08 Sep 30, 2008 | Dec '07 Dec 31, 2007 | Dec '06 Dec 31, 2006 | Dec '05 Dec 31, 2005 | Dec '04 Dec 31, 2004 | Dec '03 Dec 31, 2003 | 1998 - 2002 |
| Revenue | 0.05 | 0.05 | 0.06 | 0.1 | 0.15 | - | Upgrade
|
| Revenue Growth (YoY) | -51.63% | -17.73% | -37.93% | -34.13% | - | - | Upgrade
|
| Gross Profit | 0.05 | 0.05 | 0.06 | 0.1 | 0.15 | - | Upgrade
|
| Selling, General & Admin | 4.6 | 3.93 | 4.92 | 4.33 | 4.53 | 5.05 | Upgrade
|
| Research & Development | 6.48 | 6.04 | 1.63 | 9.07 | 10.15 | 9.93 | Upgrade
|
| Operating Expenses | 11.08 | 9.96 | 6.55 | 13.4 | 14.68 | 14.98 | Upgrade
|
| Operating Income | -11.03 | -9.91 | -6.49 | -13.3 | -14.53 | -14.98 | Upgrade
|
| Interest Expense | -0.01 | -6.64 | - | - | - | - | Upgrade
|
| Interest & Investment Income | 0.46 | 0.46 | 0.19 | 0.36 | 0.18 | 0.18 | Upgrade
|
| Other Non Operating Income (Expenses) | 0.01 | - | - | - | - | - | Upgrade
|
| EBT Excluding Unusual Items | -10.56 | -16.09 | -6.3 | -12.94 | -14.34 | -14.8 | Upgrade
|
| Pretax Income | -10.96 | -16.09 | -17.68 | -12.94 | -14.34 | -14.8 | Upgrade
|
| Income Tax Expense | - | - | - | -0.33 | -0.39 | -0.34 | Upgrade
|
| Net Income | -10.96 | -16.09 | -17.68 | -12.61 | -13.96 | -14.45 | Upgrade
|
| Preferred Dividends & Other Adjustments | 8.84 | 3.85 | 2.65 | 4.49 | 4.14 | 3.79 | Upgrade
|
| Net Income to Common | -19.8 | -19.95 | -20.33 | -17.1 | -18.09 | -18.24 | Upgrade
|
| Shares Outstanding (Basic) | 3 | 3 | 2 | 1 | 1 | 1 | Upgrade
|
| Shares Outstanding (Diluted) | 3 | 3 | 2 | 1 | 1 | 1 | Upgrade
|
| Shares Change (YoY) | -0.08% | 41.43% | 58.63% | 29.97% | 22.55% | 13.83% | Upgrade
|
| EPS (Basic) | -7.66 | -7.71 | -11.12 | -14.83 | -20.40 | -25.21 | Upgrade
|
| EPS (Diluted) | -7.66 | -7.71 | -11.12 | -14.83 | -20.40 | -25.21 | Upgrade
|
| Free Cash Flow | -9.34 | -7.96 | -7.44 | -14.05 | -13.19 | -15.99 | Upgrade
|
| Free Cash Flow Per Share | -3.61 | -3.08 | -4.07 | -12.18 | -14.87 | -22.09 | Upgrade
|
| Gross Margin | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | - | Upgrade
|
| Operating Margin | -20147.39% | -19410.73% | -10454.21% | -13299.47% | -9568.79% | - | Upgrade
|
| Profit Margin | -36186.46% | -39060.55% | -32757.76% | -17100.79% | -11917.84% | - | Upgrade
|
| Free Cash Flow Margin | -17066.99% | -15595.12% | -11983.88% | -14045.90% | -8688.55% | - | Upgrade
|
| EBITDA | -11.01 | -9.9 | -6.44 | -13.23 | -14.45 | -14.47 | Upgrade
|
| D&A For EBITDA | 0.01 | 0.01 | 0.05 | 0.07 | 0.07 | 0.5 | Upgrade
|
| EBIT | -11.03 | -9.91 | -6.49 | -13.3 | -14.53 | -14.98 | Upgrade
|
| Revenue as Reported | - | - | - | - | - | 0.18 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.